USA Health Research Published In British Journal

Researchers at the USA Health Mitchell Cancer Institute (MCI) and the University of South Alabama (USA) College of Medicine uncovered a novel mechanism that underlies castration therapy resistance in metastatic prostate cancer. Their findings were published recently in the British Journal of Cancer. Dr. Mohammad Aslam Khan, a senior research associate at MCI, is one of the project’s lead investigators. Dr. Sanjeev Srivastava, formerly a researcher at MCI and currently an analytical scientist at Johnson & Johnson, co-led the project. Contributing authors include Dr. Seema Singh, a member of the Cancer Biology Program at MCI and professor of pathology at the USA College of Medicine; Dr. Elliot Carter, professor of pathology at the USA College of Medicine; and Dr. Ajay Singh, head of the Cancer Biology and Cancer Health Disparities programs at MCI and professor of pathology at the USA College of Medicine. The research was funded through a grant awarded to Dr. Ajay Singh by the National Cancer Institute/National Institutes of Health.

Read More

87 West To Open In Downtown Fairhope

87 West To Open In Downtown Fairhope

Original Oyster House To Host Never Forget Lunch On September 11

Original Oyster House To Host Never Forget Lunch On September 11

Coastal Roots Skin Care Opens In Foley

Coastal Roots Skin Care Opens In Foley

White-Spunner Realty Adds Raley As Controller

White-Spunner Realty Adds Raley As Controller

July 2026 Housing Stats - 1

Baldwin County July 2026 “Traditional Residential” Housing Report

July 2026 Housing Stats - 1

Baldwin County July 2026 “Resort” Housing Report

United Way Of Baldwin County Announces Kickoff Luncheon

United Way Of Baldwin County Announces Kickoff Luncheon

Hanwha Offers To Buy Austal

Hanwha Offers To Buy Austal

Business Alabama Releases 2026 Legal Elite List

Business Alabama Releases 2026 Legal Elite List

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.